# Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

> **NCT01230502** · NA · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 11 (actual)

## Conditions studied

- Liver Transplant

## Interventions

- **DRUG:** Group 1 Donor Specific Regulation (DSR) +, Mycophenolic acid (MPA) monotherapy
- **OTHER:** data and sample collection
- **OTHER:** data and sample collection

## Key facts

- **NCT ID:** NCT01230502
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-11
- **Primary completion:** 2012-05
- **Final completion:** 2012-06
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** insufficient study population to meet study objective
- **Last updated:** 2014-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01230502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01230502, "Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01230502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*